SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-319381
Filing Date
2013-08-05
Accepted
2013-08-05 17:22:50
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d548746d10q.htm 10-Q 487078
2 EX-31.1 d548746dex311.htm EX-31.1 6930
3 EX-31.2 d548746dex312.htm EX-31.2 6947
4 EX-32.1 d548746dex321.htm EX-32.1 3273
5 EX-32.2 d548746dex322.htm EX-32.2 3256
  Complete submission text file 0001193125-13-319381.txt   4801247

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cndo-20130630.xml EX-101.INS 368328
7 XBRL TAXONOMY EXTENSION SCHEMA cndo-20130630.xsd EX-101.SCH 43345
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cndo-20130630_cal.xml EX-101.CAL 40609
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cndo-20130630_def.xml EX-101.DEF 144354
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cndo-20130630_lab.xml EX-101.LAB 323395
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cndo-20130630_pre.xml EX-101.PRE 211563
Mailing Address 24 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address 24 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803 781-652-4500
CORONADO BIOSCIENCES INC (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35366 | Film No.: 131011086
SIC: 2834 Pharmaceutical Preparations